ALGS: Gunggung utang perusahaan Aligos

Aligos Therapeutics (ALGS) focuses on combination therapy for hepatitis B, employing a multifaceted approach to cure patients. Strong confidence from the scientific community confirms its status as a reliable developer. However, fierce competition in the NASH segment and capital requirements create financial risks. The debt trend illustrates the dynamics of liabilities, with the 0.00 metric serving as the target level.

Aligos Therapeutics Inc. - Utang perusahaan ALGS (periode 04.07.2022 - 28.10.2026)

Rincian analitis lan laporan data perusahaan Aligos Therapeutics (ALGS)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega aligos.com|ALGS - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Aligos|ALGS - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham Aligos Therapeutics|ALGS - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih aligos.com|ALGS - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Aligos Therapeutics|ALGS - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal aligos.com|ALGS - Utang perusahaan|Rasio utang marang kapitalisasi buku Aligos

Analisis fundamental perusahaan:ALGS Aligos Therapeutics Inc.

The scientific reputation of Aligos Therapeutics (ALGS) in developing hepatitis B therapies enables the company to attract capital, yet the debt load trend reflects the aggregate of all the issuer's credit obligations and bonds. Analyzing this metric allows for an assessment of default risks and borrowing costs, where a reduction in the debt base confirms financial stability and enhances the company's investment attractiveness.

Pesaing wigati

Kewajiban utang agregat Arrowhead Corp (ARWR)|Gunggung utang perusahaan MIRM (Mirum Pharmaceuticals)|Dynavax Pharma - Gunggung utang perusahaan|Utang perusahaan Arbutus Biopharma Corporation (ABUS)|IVA: Kewajiban utang agregat|GYRE (Gyre Corp) - Utang perusahaan|Assembly Corp (ASMB) - Gunggung utang perusahaan|GALT (Galectin Therapeutics, Inc.) - Gunggung utang perusahaan|Gunggung utang perusahaan Genfit Corp (GNFT)|DURECT Corporation (DRRX) - Gunggung utang perusahaan|Kewajiban utang agregat BIVI (biovieinc.com)|Utang perusahaan Galmed Pharmaceuticals Ltd. GLMD|Utang perusahaan ENDRA Corp NDRA|Gunggung utang perusahaan HEPA (Hepion Pharma)